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The immune response (I) region of  the mouse 1-1-2 major histocompatibility complex 
regulates interaction  between thymus-derived (T)  and bone-marrow-derived (B)  lympho- 
cytes  that  result  in  antibody  synthesis (reviewed  in  references I  and 2).  Immune response 
(Ix)  genes control  specific  immune responses  to  various synthetic and native antigens (3) 
but their  cellular  site  of  action (T cells  and/or B cells)  remains unresolved (reviewed in 
reference 4)./-region  compatibility  may (5,  6)  or  may not (2,  7-9)  be  required  for  optimal  T 
cell  - B cell  collaboration  during a secondary IgG antibody response. The/-region also 
determines a highly polymorphic series of membrane  glycoproteins of approximately 
30,000  mol wt denoted as/-region-associated (Ia)  ~  antigens. These antigens are  expressed 
predominantly on B cells  (reviewed in reference 1),  may serve as a B-cell  differentiation 
marker (10),  2  may mediate certain steps  of  the switch from IgM to IgG antibody produc- 
tion°  (10, 11),  and are purported to be components of antigen-specific  helper (12)  and 
suppressor (13)  factors  as well as an antigen-nonspecific helper (14)  factor.  Implicit in 
these results  is  the involvement of  Ia antigens in  Ir gene function.  However, the precise 
definition  of  this  relationship  as  demonstrated by  the  cellular  origin  of  these  factors,  their 
target and mechanism  of action, and the role of their la molecules in lymphocyte 
interaction is still  not yet clear. 
Allogeneic  effect  factor  (AEF) has  been identified  as  an antigen-nonspecific,  soluble,  T- 
cell-derived,  helper  factor  that  mediates in  vitro  B-cell  activation  in a manner similar to 
the  in  vivo  allogeneic  effect  (14).  The active  components of  this  AEF have  been  reported  to 
be la antigens (15)  and B2-microglobulin  (16).  However, so far it has been difficult  to 
demonstrate directly  the presence of  la antigens on helper  T cells  (10).  In  addition,  AEF 
activity  seems to reside with proteins of  mol wt of  40-45,000 and 12,000  daltons,  respec- 
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tively. This chromatographic profile closely resembles that obtained upon isolation of  H-2 
antigens (17). 
The experiments described in this report were performed to determine the immune- 
chemical nature and cellular origin of AEF to further elucidate the role of Ia antigens in 
T cell-B-cell interaction. AEF was produced in an H-2 congenic strain combination by an 
initial in vivo allogeneic activation and was harvested from the culture medium of a 
mixed lymphocyte culture reaction (MLR) between activated responder cells and irradi- 
ated  stimulator cells.  This  AEF  can  provide helper cell function  for  a  primary  and 
secondary antibody response  of both responder strain and  stimulator strain spleen B 
cells. Ia antigens derived from both the activated responder and irradiated stimulator cell 
populations are present in this AEF. By contrast, an AEF generated in the presence of Ia- 
negative activated responder cells and irradiated T-cell-depleted stimulator cells helps 
hapten-primed B  cells of only the stimulator hapiotype. It contains Ia antigens deter- 
mined only by the stimulator haplotype and not the responder haplotype. The data sug- 
gest that this genetically restricted AEF is an Ia-positive helper factor produced by either 
a  B cell and/or macrophage. They also indicate that the haplotype specificity observed is 
mediated by the interaction of Ia antigens in restricted AEF and Ia antigens on a B cell, 
which activates hapten-primed B cells to IgG antibody production. Preliminary reports of 
these data have been previously published (10, 18,  19). 
Materials and Methods 
Mice.  All inbred strains of mice used were maintained in our colony at Stanford University or 
at University of Toronto. 
Antigens.  A single batch (batch 03) of sheep erythrocytes (SRBC),  previously determined to 
elicit a high direct plaque-forming cell (PFC) response, was purchased from Grand Island Biologi- 
cal Co.,  Grand Island, N.Y.  Burro erythrocytes were purchased from  Woodlyn Laboratories, 
Guelph, Ontario, Canada. Keyhole limpet hemocyanin (KLH) was supplied by Pacific Biomarine 
Supply Co., Venice, Calif. Conjugates of 2,4-dinitrophenyl (DNP) DNPI1-KLH  (per 105 daltons) 
were prepared as previously reported (20). 
Immunizations.  Mice were injected intraperitoneally with either 5 ×  10  s SRBC in Dulbecco's 
phosphate-buffered saline or 100  /zg of alum precipitated DNPI~-KLH mixed with 2 ×  10  ~ heat- 
killed  Bordetella pertussis organisms (purchased from Connaught Medical Research Laboratory, 
Willowdale, Ontario, Canada). They were sacrificed 8-12 wk later and used as primed spleen cell 
donors. 
Antisera.  Anti-H-2 and anti-Ia mouse  alloantisera were produced in the following strain 
combinations by hyperimmunization of recipient mice with donor spleen and lymph node cells (21); 
anti-K  k, (A.TL x  B10.A[5R])  F~ anti-B10.A; anti-IT, (C3H.SW ×  B10.A[2R]) F~ anti-C3H; anti- 
Ia  k, A.TH anti-A.TL; anti-K  ~, (A × A.AL) F~ anti-A.TL (this serum was a kind gift from Dr. D. 
Shreffier, Washington University, St. Louis, Me.); anti-I~, A.TH anti-A.SW and anti°Ia  ~, A.TL 
anti-A.TH. The anti-Ia  k and anti-Ia  ~  sera were rendered specific by in vivo absorption in B10.S(H- 
T) and B10.BR(H-T) mice, respectively (22). A rabbit antiserum against the X5583 IgG2~ myeloma 
protein (RAMP) was produced as previously described (23) and shown by immunodiffusion to react 
with all classes ofmouse immunoglobulin. The congenic anti-Thy 1.2 sera, [A  Thy~'I × AKR.H.2  b] F~ 
anti-ASL1 (generously supplied by Dr.  U. H~immerling, Sloan-Kettering Institute, New York, 
N.Y.)  and  AKR/J  anti-AKR/Cum were  used  for  the  identification and depletion of T  cells, 
respectively. 
Preparation of  AEF.  AEF was produced by a procedure similar to that previously reported (14) 
by using H-2 congenic mouse strains. B10.BR(H-2 k) lymphocytes were allogeneically activated 
against H-T antigens by intravenous injection of irradiated (800 rad) B10.S(H-2 ~) recipients (2-3 
me old) with 1-2 × 108 B10.BR donor (1-2 me old) thymocytes. 5 days later, approximately 90% of 
recipient spleen cells were found to be activated T cells of  donor H-2 haplotype, as tested with anti- 
Thy 1.2 and anti-K  k sera in the presence of rabbit complement by a  dye exclusion cytotoxicity 
assay (21). Each recipient spleen yielded about 1.5-2.5 × 107 cells. Cell suspensions were prepared 
at 2 × 107 cells/ml in serum-free Click's medium (24) supplemented with 4 mM glutamine and 5 × TERRY  L.  DELOVITCH  AND  HUGH  o.  McDEVITT  1021 
10  -~ M  2-mercaptoethanol immediately before use.  Equal numbers (107)  of activated responder 
B10.BR cells  and normal irradiated  (3,000  rad) stimulator B10.S spleen cells  were cocultured in  a 
vol  of  1  ml  by rocking  in  a moist  5% CO2 atmosphere. Allogeneic supernates (AEF) of  20-24 h MLR 
were harvested by centrifugation  at 2,500  rpm for 15 rain,  filtered  through an 0.22-~tm Millipore 
filter  (Millipore  Corp.,  Bedford, Mass.) previously washed with serum-free Click's  medium and 
stored  in  samples at -70°C for  as  long  as  3 wk without any significant  loss  of  activity.  Both the in 
vivo and in vitro  activation steps  described here were found to be necessary to generate AEF 
activity  as assayed below. 
A  technique has been developed which allows a direct  correlation  to be made between the 
selective  expression of la determinants amongst functional lymphocyte subpopulations  with a 
particular  functional  role  for  la  antigens  in  the  regulation  of  the  immune response by  either  T cells 
(20)  or B cells  (25).  The method is  dependent upon the elimination of  specific  functional lympho- 
cyte  subpopulations bearing  surface  la antigens by  treatment with anti-Ia  serum and complement 
(18,  20, 25).  This negative selection  procedure was adapted for the identification  of  the cellular 
origin  of  AEF. 
Ia-negative activated responder B10.BR spleen cells  were prepared by treatment of 10  s cells 
with 1 ml of anti-la  k diluted 1:5 for 20 rain  at room temperature.  Cells  were centrifuged and 
resuspended in 3 ml of  rabbit complement diluted 1:9  and incubated for  a further 45 rain  at 37°C, 
then washed twice and resuspended in serum-free Click's  medium before culture.  Approximately 
10-25% of  the cells  were specifically  lysed by this  procedure. T-cell-depleted  normal stimulator 
B10.S spleen cells  were prepared under similar  conditions  by reactivity  with anti-Thy-l.2  (AKR/J 
anti-AKR/Cum)  and rabbit complement. The latter  treatment resulted in 25-35% specific  cell 
lysis. 
Immunoadsorbent  Fractionation of AEF.  IgG fractions were isolated from 2-3 ml of various 
mouse alloantisera by ammonium sulfate precipitation and DEAE cellulose chromatography in 
0.04 M potassium phosphate buffer, pH 8.0.  Approximately 6 mg of IgG was coupled to cyanogen- 
bromide activated Sepharose 4B (Pharmacia Fine Chemicals Inc., Piscataway, N.J.) (26) and the 
conjugate  packed  in  a  1  x  3-cm  column.  Each  amount  of conjugated  IgG  was  serologically 
estimated to be in excess of the amount of antigen potentially present in AEF. A similar column 
was formed by using about 10 mg of the IgG fraction from RAMP, prepared by passage through 
DEAE cellulose in 0.01  M  phosphate  buffer,  pH 7.4,  containing 0.15  M  NaCl.  Antigen-coated 
columns were also formed by coupling 10 mg of either DNPI1-KLH or KLH to CNBr-activated 
Sepharose 4B. 
AEF was added to and incubated on a column during 1 h at 4°C, unbound components were then 
eluted with phosphate-buffered saline (0.02 M phosphate, pH 7.4, 0.15 M NaCl), filtered through a 
0.22-~m Millipore filter (Millipore Corp.) and immediately added at the appropriate dilution to in 
vitro spleen cell cultures. 
In Vitro Antibody Responses.  Primary  anti-SRBC  and  secondary  anti-DNP  PFC responses 
were evaluated in  a  microculture  assay  similar to that  devised by Armerding and  Katz  (15). 
Spleen cells (10  s) derived from either nonimmunized or DNP-KLH-primed donors were suspended 
in Click's medium containing 5% fetal calf serum (Click-FCS) and cultured in a  0.3-ml vol in a 
Mictrotest II Falcon tissue culture plate (Falcon Plastics, Division of BioQuest, Oxnard, Calif.) for 
either 5 days with 3  ×  l0  s SRBC or 6 days with  1 ng/ml of DNP-KLH. AEF at concentrations 
between 10 and 50% was introduced into appropriate cultures before the addition of spleen cells. T- 
cell-depleted, DNP-KLH-primed spleen B cells were prepared by treatment of l0  s spleen cells with 
1 ml (diluted h5) of an anti-Thy 1.2 serum (AKR/J anti-AKR/Cum) for 20 min at room tempera- 
ture and 3 ml of rabbit complement for a  further 45 min at 37°C,  then washed three times with 
Click-FCS and added to the cultures. This treatment resulted in 30-40% cell lysis. The surviving 
cell population was found to contain routinely less than 3% of Thy-l.2-bearing cells, as assayed by 
immunofluorescence by using a fluorescein-conjugated AKR/J anti-AKR/Cum serum and a Leitz 
Orthoplan fluorescence microscope (E. Leitz, Inc., Rockleigh, N.J.) equipped with Ploem illumi- 
nation. 
Cells from triplicate wells were pooled, harvested,  and their PFC responses analyzed by the 
Cunningham and Szenberg modification of the Jerne assay (27). SRBC were used as indicator cells 
for the primary anti-SRBC PFC response. Anti-DNP indirect PFC were developed by using RAMP 
and 2,4,6-trinitrophenyl-coupled burro erythrocytes (20). 1022  AN  Ia-POSITIVE  ALLOGENEIC  EFFECT  FACTOR 
TABLE  I 
Strain Distribution Analysis of Helper Cell Function of AEF in an In Vitro Primary 
Anti-SRBC Response 
H-2 Regions  Direct PFC/1os-cultured 
Strain  I  Spleen cells  Antigen  cells 
(I x los)  (3 × los  SRBC) 
K  A  B  J  E  C  S  G  D  NoAEF  AEF(50%) 
BI0.BR  k  k  k  k  k 
B10.S  s  s  s  s  s 
B10.A  k  k  k  k  k 
BI0.A(4R)  k  k  b  b  b 
BI0.D2  d  d  d  d  d 
BI0  b  b  b  b  b 
BI0.A(5R)  b  b  b  k  k 
k  k  k  k  Untreated  176 (1.22)  295 (1.18) 
+  3,143 (1.07)  9,386 (1.05) 
Anti-Thy 1.2 treated  221 (1.20)  370 (1.18) 
+  294 (1.22)  4,987 (1.07) 
s  s  s  s  Untreated  338 (1.13)  798 (1.06) 
+  2,742 (1.08)  0,938 (1.06) 
Anti-Thy 1.2 treated  80 (1.0~)  199 (1.11) 
+  246 (1.24)  5,845 (1.03) 
d  d  d  d  Untreated  299 (1.07)  447 (1.12) 
+  3,590 (1.09)  9,878 (1.07) 
Anti-Thy 1.2 treated  124 (1.37)  286 (1.19) 
+  274 (1.24)  4,188 (1.08) 
b  b  b  b  Untreated  945 (1.11)  990 (1.16) 
+  7,965 (1.10)  16,358 (1.08) 
Anti-Thy 1.2 treated  98 (1.22)  545 (1.12) 
+  595 (1.14)  6,230 (1.08) 
d  d  d  d  Untreated  358 (1.12)  597 (1.11) 
+  4,092  (1.06)  11,384 (1.05) 
Anti-Thy 1.2 treated  345 (1.19)  548 (1.12) 
+  442 (1.20)  5,897  (1.03) 
b  b  b  b  Untreated  267 (1.16)  346 (1.15) 
+  2,038  (1.10)  2,742 (1.08) 
Anti-Thy 1.2 treated  191 (1.30)  546 (1.14) 
+  294 (1.22)  647 (1.10) 
d  d  d  d  Untreated  29T (1.14)  297 (1.18) 
+  3,943 (1.07)  4,089  (1.08) 
Anti-Thy 1.2 treated  245 (1.22)  548 (1.12) 
+  294 (1.22)  647 (1.10) 
Either 1 ×  l0  s untreated or anti-Thy 1.2 (AKR/J anti-AKR/Cum) plus complement-treated  cells were cultured in 0.3 ml of Click's 
medium (23) containing 5% FCS in the absence (-) or presence (+) of SRBC (3 ×  los) and AEF (50%) for 5 days. Direct PFC were 
analyzed by the Cunningham  and Szenberg method (27)  and are expreased as geometric means with standard errors in paren- 
theses. 
Results 
Strain  Distribution Analysis  of AEF Helper  Cell Function  in  a  Primary 
Response.  The enhancement and helper T-cell replacing activity of AEF in an 
in vitro primary anti-SRBC response of spleen cells derived from several H-2 
haplotypes is presented in Table I. An insignificant indirect PFC response was 
obtained with these cells and is therefore not shown here. The genotypes of the 
H-2 congenic inbred and recombinant strains tested are indicated. It is evident 
that AEF generated in a serum-free medium augments by approximately three- 
fold the response of untreated spleen cells and reconstitutes the response of T- 
cell-depleted spleen B cells of both responder B10.BR origin and B10.S stimula- 
tor origin. These two properties have been previously reported (14) for an AEF 
prepared in a serum-containing medium and in an alternate strain combination, 
DBA/2 (H-2  ~) activated against C3H(H-2k), that allowed for stimulation across 
H-2 as well as non-H-2 differences. However, in this latter combination, AEF 
displayed preferential activity towards responder DBA/2 cells. It was only after TERRY  L.  DELOVITCH  AND  HUGH  O.  McDEVITT  1023 
partial purification that this AEF worked efficiently with C3H stimulator cells. 
The triggering of both the responder and stimulator PFC responses by AEF 
could be due to a nonspecific mitogenic signal, or AEF could be comprised of 
molecules of both B10.BR and B10.S origin. The former possibility is unlikely 
since AEF reconstituted the B10.A,  B10.A(4R), and B10.D2 responses, but not 
the B10 nor B10.A(5R) responses. A similar result was observed for the response 
of C57B1/6 (14), which possesses the same H-2 haplotype (H-2  b) as B10. It is 
possible that in the T-cell-depleted B10 and B10.A(5R)  cultures, B cells may 
proliferate but may not differentiate into antibody-producing  cells upon addition 
of AEF at  the beginning of the culture period.  Addition of AEF to  similar 
cultures  during  the  last  48-60  h  of culture  stimulate  antibody  production 
whereas these allogeneic supernates are not required to induce B-cell prolifera- 
tion (28). However, use of either this procedure or addition of AEF both at the 
beginning and during the last 48 h of culture proved unsuccessful in attempts to 
elicit a B10 and B10.A(5R) response. These data suggest that the ability of AEF 
to provide T-cell helper function during interaction with unprimed B cells may 
be determined by genes localized in the K end of the H-2 complex; no indication 
of whether  K or I region genes control this effect can be inferred. The pattern of 
reactivity cannot be attributed to the distribution of known Ia antigenic specific- 
ities in these strains. 
AEF Helper Cell Activity and Imrnunochemical Characterization  in a Second- 
ary Response.  The helper cell replacing function of AEF was also assessed in a 
secondary in vitro T-cell-dependent  system. Fig. 1 illustrates the activity of  AEF 
in the secondary anti-DNP indirect PFC response of untreated and anti-Thy-l.2 
(AKR/J anti-AKR/Cum) plus complement-treated  spleen cells from B10.BR and 
B10.S  DNP-KLH primed donors.  The low direct PFC  response  (200 PFC/10  z 
cultured cells) observed with untreated spleen cells is not shown. Untreated 
B10.BR DNP-KLH-primed spleen cells produced an indirect PFC response that 
was usually 500-1,000 PFC greater than that achieved by B10.S-primed cells. 
The response of each of these cell populations was not significantly increased by 
the addition of AEF at a final concentration of 50%, or at a concentration of 25% 
(results not shown). These concentrations of AEF each fully reconstituted the 
responses of anti-Thy-l.2-treated B10.BR and B10.S spleen cells. Approximately 
only half this level of reconstitution was achieved with AEF used at a 10% final 
concentration. However, AEF tested at the above concentrations did not restore 
the response of T-cell-depleted B10  cells (T.  Delovitch, unpublished observa- 
tions).  Hence,  this  pattern  of reconstitution of helper  cell  function  in  the 
secondary anti-DNP response paralleled that obtained for the primary SRBC 
response (Table I) and confirmed the lack of antigenic specificity of AEF. 
Based on the ability of a cross-reactive anti-Ia serum to absorb AEF activity, 
and on the molecular size of the active AEF components, Armerding et al. (16) 
concluded that AEF contains Ia antigens. However, the serum used by these 
investigators also contained potential cross-reactive antibodies against H-2K 
antigens.  No  evidence was  presented to  determine whether the  absorptive 
capacity of this serum was due to its anti-Ia or its anti-H-2K activity. For this 
reason, the role of Ia antigens in an AEF induced in vitro immune response was 
examined. 
The nature of AEF was determined by testing its activity after fractionation 1024  AN  Ia-POSITIVE  ALLOGENEIC  EFFECT  FACTOR 
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FIG.  1.  Functional and immunochemical analysis of AEF activity in a secondary in vitro 
anti-DNP response. Culture conditions and anti-Thy 1.2  treatment were similar to that 
described in Table I. Untreated and anti-Thy 1.2-treated spleen cells from either B10.BR or 
B10.S DNP-KLH-primed mice were cultured with or without DNP-KLH (1  ng/ml) in the 
absence  or  presence of unfractionated or  immunoadsorbent column  fractionated AEF. 
Indirect PFC were evaluated after 6 days of culture by using trinitrophenyl-coupled  burro 
RBC  (19) and  are  presented as  standard errors of the  geometric mean.  Sera  used  for 
immunoadsorption are as described in Materials and Methods. 
on various immunoadsorbents.  A concentration  (50%) of AEF corresponding to 
the  plateau  of its activity was used after column fractionation.  Similar  data 
were obtained for both B10.BR and B10.S cell populations  (Fig.  1). Absorption 
on an anti-Ia  k or on an anti-Ia  s column each resulted in a  loss of 80% of AEF 
activity when compared to the activity of a similar concentration of unabsorbed 
AEF. The possibility that this absorption of AEF activity is due to a  threshold 
effect is unlikely since the same results were observed with AEF at concentra- 
tions between 20 and 50%  (results not shown). The anti-Ia  sera used here, by 
virtue of their method of preparation,  do not contain detectable anti-H-2K  or 
anti-H-2D activity. Serial passage of AEF through these two anti-Ia immunoad- 
sorbent columns completely abrogated its activity. By contrast, no AEF activity 
was removed by an  anti-K  k,  anti-I~,  anti-K  s,  anti-I~,  or a  polyvalent rabbit 
anti-mouse  IgG  (RAMP)  column.  These  results  confirmed  those  previously 
obtained for the primary SRBC response by using identical anti-Ia and anti-Ig 
columns  (T.  Delovitch, unpublished  observations).  By these criteria,  it would 
appear that the active components of AEF consist, in part, of Ia antigens derived 
from both responder B10.BR and stimulator B10.S cells. 
Cellular Origin of  AEF.  It has been generally assumed that AEF is a T-cell 
product because (a) AEF can replace T-cell-dependent helper function (14,  28); TERRY  L.  DELOVITCH  AND  HUGH  O.  McDEVITT  1025 
(b)  adherent cells are apparently not required for AEF production (D.  Katz, 
personal communication) nor do they seem to produce it in significant amounts 
(28); (c) AEF has been postulated to be an inductive signal for the differentiation 
of antigen-sensitive B cells into antibody-forming cells (28); and (d) the alloge- 
neic effect in vitro has been purported to be mediated by direct interaction of 
AEF with the responding B cells (14). However, in view of the above indications 
that Ia antigens derived from both responder and stimulator cells are molecular 
constituents of AEF, it is conceivable that AEF is not a T-cell product. 
To test this possibility, the activity of AEF prepared from mixtures of subpop- 
ulations of responder and stimulator cells was analyzed. An assay was devised 
which selected for the generation of AEF activity by stimulator B cells in the 
MLR, and selected against the generation of AEF activity by responder T cells 
in the MLR. This experiment was considered feasible since responder T cells in 
the MLR are considered to be Ia negative as demonstrated by their capacity to 
respond after treatment with anti-Ia and complement, and because isolated B 
cells, which are Ia positive, stimulate strongly in an MLR (18, 29). The latter 
observations also tend to eliminate the responder T cell as a possible source of Ia 
antigens in AEF and raise the possibility that AEF Ia molecules may be derived 
from a B cell and/or macrophage of the stimulator cell population. 
The negative selection procedure for the preparation of this AEF was per- 
formed as  follows.  B10.BR(H-2 k)  thymocytes were activated in vivo  against 
B10.S(H-T)  cellular alloantigens as described (see Materials and Methods) and 
then reacted in vitro with anti-Ia  k and complement to deplete this responder 
population  of Iak-positive  cells.  Normal  B10.S  stimulator  spleen  cells were 
treated with anti-Thy-l.2 and complement to eliminate any T cells which could 
potentially recognize residual  Iak-positive  cells in  the  responder spleen  cell 
pepuJation. Both of these treatments were designed to minimize the production 
of responder Ia  k antigens and stimulator T-cell-derived Ia  s antigens in AEF. 
AEF was produced in 24 h mixed lymphocyte  cultures of Ia-negative responder T 
cells  and  irradiated,  T-cell-depleted,  stimulator  Ias-positive  spleen  cells.  A 
strong MLR response is obtained with similar cultures (containing normal Ia 
negative responder T cells and irradiated T-cell-depleted Ia-positive spleen cells) 
maintained for 96 h  (T.  Delovitch, unpublished observations). The activity of 
this AEF was then tested for its ability to interact with either B10.BR or B10.S 
DNP-KLH-primed, T-cell-depleted, spleen B cells. 
It is evident from Fig.  2 that AEF produced in the above manner (AEF-I) 
reconstituted the secondary anti-DNP response of B10.S T-cell-depleted-primed 
spleen cells but not B10.BR T-cell-depleted-primed  spleen cells. By contrast, an 
AEF (AEF-II) derived from a MLR between irradiated, T-cell-depleted, stimula- 
tor B10.S spleen cells and activated responder B10.BR cells that were pretreated 
with anti-Ia  s and complement, which would not be expected to cause the lysis of 
these  cells,  reconstituted both  the  B10.BR  and  B10.S  secondary anti-DNP 
responses. The latter result is similar to that obtained with AEF produced by 
the usual protocol by using untreated B10.BR  responder cells and untreated 
B10.S stimulator cells (see Fig. 1). Thus, AEF-I, generated in the presence of Ia- 
negative responder T cells and T-cell-depleted stimulator cells (a) possesses a 
definite H-2 haplotype restriction in its activity, and will be termed restricted 
AEF and (b) may be a B-cell product which can stimulate only B cells that bear 1026  AN  Ia-POSITIVE  ALLOGENEIC  EFFECT  FACTOR 
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FIG.  2.  Haplotype restriction of AEF activity. AEF activity was analyzed with supernates 
from mixtures of activated B10.BR responder cells, which were pretreated with either anti- 
Ia  k (AEF-I) or anti-Ia  s (AEF-II) plus complement, and anti-Thy 1.2 plus complement-treated 
irradiated B10.S stimulator cells. Culture conditions and evaluation of PFC were as noted 
in Fig. 1. 
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FIG.  3.  Immunoadsorption of  restricted AEF activity. AEF-I and AEF-I! were produced as 
described in Fig. 2. Immunoadsorption on anti-Ia  k and anti-Ia  s columns, culture conditions, 
and evaluation of PFC were as described in Fig. 1. 
similar Ia antigens. It should be noted, however, that macrophages present in 
the stimulator cell population may also potentially serve as a source of  restricted 
AEF. 
To examine further the possibility that restricted AEF Ia antigens are derived 
from a stimulator B cell, the removal of restricted AEF activity by anti-Ia  k and 
anti-Ia  '~ immunoadsorbent columns was tested. If the Ia antigen components of 
restricted  AEF  are  derived from the  B10.S  (H-2  ~)  stimulator B  cell  (and/or 
macrophage), then the prediction would be that an anti-Ia  s column but not an 
anti-Ia  k column should adsorb its activity. As is demonstrated in Fig. 3, approxi- 
mately 90% of  the capacity of restricted AEF (AEF-I) to stimulate the secondary 
anti-DNP response of B10.S  DNP-KLH-primed T-cell-depleted spleen B  cells 
was eliminated by adsorption on an anti-Ia  ~ column but not adsorption on an 
anti-Ia  k column. However, both the anti-Ia  k and anti-Ia  '~ columns removed the TERRY  L.  DELOVITCH  AND  HUGH  O.  McDEVITT  1027 
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Fie.  4.  Failure of antigen-immunoadsorbents  to remove  restricted AEF  activity. The 
activity of restricted AEF  was tested either before or after adsorption on a DNP-KLH  or 
KLH-coated column. 
activity of AEF-II produced by an  MLR between anti-Ia  s and  complement- 
treated activated B10.BR responder cells and T-cell-depleted, irradiated, B10.S 
stimulator  spleen cells.  This  result  is  comparable to  that  obtained  for the 
conventionally produced AEF (see Fig. 1). 
The above data clearly indicate that whereas Ia antigens in AEF produced in 
the usual manner are products of both the responder cell and the stimulator cell 
populations, restricted AEF Ia molecules are derived only from the stimulator 
cells. The source of Ia antigens in the responder cell population is not known. 
Since the responder T cell in an MLR has been purported to be Ia negative, AEF 
Ia antigens derived from the responder cell population must be products of non- 
MLR responsive T cells and/or the low proportion (approximately 5%) of B cells 
in this population. 
Role of Antigen in Restricted AEF.  The activity of antigen-specific, T-cell- 
derived (12, 13) and macrophage-derived (30) Ia-positive factors may be removed 
by antigen  immunoadsorbents. It  is  not clear whether the  antigen-binding 
properties of these factors indicate that they are molecularly associated with 
antigen or otherwise serve as specific antigen receptors. To determine whether 
restricted AEF can bind antigen, the adsorption of its activity by either a DNP,- 
KLH or KLH column was tested. 
Passage of restricted AEF over each of these antigen columns failed to remove 
any of its helper activity in a  secondary anti-DNP response of DNP-primed 
B10.S B cells (see Fig. 4). This result suggests that antigen is not a component of 
restricted AEF. However, it does not rule out the possibility that restricted AEF 
may become complexed with antigen in culture during the course of the 6-day in 
vitro secondary antibody response. Thus, it still may be possible that the B cell 
is triggered by antigen in association with Ia determinants of AEF in a manner 
similar to that previously described for a factor which mediates macrophage-T- 
cell interaction (30). 
Discussion 
To further delineate the central role that Ia antigens play in the regulation of 
T cell-B cell-macrophage collaboration during an immune response, an alloge- 1028  AN  Ia-POSITIVE  ALLOGENEIC  EFFECT  FACTOR 
neic effect factor was characterized with respect to  its  helper cell replacing 
activity, immunochemical  nature, H-2 haplotype specificity, genetic origin, and 
cellular origin. 
Unlike an AEF previously generated by an H-2 and non-H-2 incompatibility 
(14), the AEF produced here across only an H-2  difference is not genetically 
restricted in its activity as it enhances a  primary antibody response of both 
responder  and  stimulator  spleen  cells.  This  AEF  also  provides  helper  cell 
function in a primary and secondary antibody response for both responder and 
stimulator T-cell-depleted spleen B cells.  The pattern of reactivity of AEF in a 
primary response with B cells of several inbred and recombinant strains sug- 
gests  that  genes  in  the K,  I-A,  and  I-B  regions  may control  this  type  of 
interaction. These data differ from those reported for a soluble factor, produced 
by a similar procedure of alloantigen-activation across an H-2 difference, that 
suppresses a mixed lymphocyte reaction (31). This suppressor factor expresses 
antigen specificity towards the responder cell and not the stimulator cell, and 
this phenomenon is apparently determined by the PC subregion. 
An immunochemical analysis of AEF activity established that Ia antigens, 
but neither H-2 antigens nor immunoglobulins, represent an active component 
of AEF. These data, taken together with those suggesting the K, I-A, and I-B 
region control of AEF activity, imply that only one or both of the latter two 
regions may control this activity. Since an antigen-spec~c T-cell-derived sup- 
pressor cell factor seems to be comprised of Ia antigens determined by genes in 
the I-J subregion situated between the I-B and I-E subregions (32), it would 
appear that Ia determinants of helper and suppressor cell factors are controlled 
by different/-region  genes. This idea derives additional support from the finding 
that an anti-Ia serum which inactivates allotype suppressor T cells does not 
affect helper T-cell activity (10). Nevertheless, no  Ia  molecul~ with  known 
specificities may as  yet be  assigned  as  a  component of either a  helper or 
suppressor cell factor. 
Immunoadsorption on anti-Ia columns of the activity of AEF produced in the 
usual manner provided two interesting observations. First, AEF is comprised of 
Ia antigens derived not only from activated responder cells but also from the 
irradiated stimulator cells.  Second, since about 75%  of AEF activity was re- 
moved by each of the anti-Ia sera reactive with the responder and stimulator 
haplotypes and since AEF activity was completely removed by a combination of 
these two  antisera,  this  implies  that a  complex is  formed between AEF Ia 
antigens derived from the two haplotypes. If a complex between these antigens 
does exist, it is not clear whether (a) it represents a  covalent or noncovalent 
interaction, (b)  it plays a role, as such, in vivo during allogeneic lymphocyte 
interaction or, (c) it merely arises artifactually during an in vitro MLR from the 
formation of membrane vesicles released from the responder and stimulator cell 
populations. Further experimentation should resolve these possibilities. 
The characterization of an AEF produced in an MLR between Ia-negative 
responder cells and T-cell-depleted stimulator cells confirmed the above data 
that AEF Ia antigens may also originate from the stimulator haplotype. More 
significantly, the stimulator B cell was implicated as one source of Ia antigens 
present in AEF. This AEF stimulated the secondary antibody response of T-cell- 
depleted B cells of  the stimulator but not responder haplotype. While the genetic TERRY  L.  DELOVITCH  AND  HUGH  O.  McDEVITT  1029 
origin of this haplotype restricted AEF and AEF generated by the usual proce- 
dure has not yet been mapped precisely within the/-region, it is clear that 
genetic differences exist in the patterns of helper cell replacing function dis- 
played by these two AEF preparations. These reactivities may be explained by 
the different origins of the two factors.  Restricted AEF  is  a  product of the 
stimulator B cell and/or macrophage and may be able to help only B cells of its 
own haplotype, or of haplotypes sharing identical Ia antigens. By analogy, AEF 
produced in  the  usual  manner  contains Ia  antigens derived from beth  the 
responder and stimulator cells, and may therefore be able to stimulate B cells of 
a  wider range  of H-2  haplotypes which possess similar or cross-reacting Ia 
determinants. 
Whether the stimulator B  cell is a  source of restricted AEF has not been 
difinitively determined. It is possible that this AEF is also derived from the 
residual stimulator T cells which constitute less than 3% of the T-cell-depleted 
stimulator cell population. Macrophages, which bear Ia determinants (33, 34) 
and produce a soluble Ia-pesitive helper factor that mediates T-cell macrophage 
interaction (30), may also be present in the stimulator cell population and serve 
as a  potential source of restricted AEF.  However, it has been reported that 
macrophages are apparently not required for AEF production, nor do they seem 
to produce it in detectable amounts (28). It is suggested, therefore, that the 
major source of restricted AEF is the stimulator B  cell because of the high 
proportion of B  cells  in  the  stimulator  cell  population and  because  of the 
predominant expression of Ia antigens by B cells. While AEF produced in the 
usual manner also originates from the responder cell population, the source of  Ia 
antigens in this population remains unknown. What is apparent is that the 
responder T cell does not produce the ~'~ antigens present in AEF. 
Considerable evidence has indicated that allogeneic T cell-B-cell interaction 
during an immune response may occur via the specific recognition of Ia antigens 
on hapten-primed B cells by allogeneic T cells. For example, the allogeneic effect 
(35) is  manifested by  the  recognition by  allogeneic T  cells  of alloantigens 
(possibly Ia molecules) on hapten-primed B cells, which then potentiates an IgG 
secondary anti-hapten  response  to  hapten  on a  heterologous carrier  in  the 
absence of syngeneic carrier-primed T cells. Similarly, (T,G)-A-L primed nonre- 
sponder spleen B  cells can switch from IgM to IgG antibody production upon 
stimulation by allogeneic T cells but not syngeneic T cells (36). Ia antigens are 
considered to be the major determinants recognized in an MLR and graft-versus- 
host reaction (reviewed in references I and 18) and may also serve a recognitive 
role in the allogeneic effect. These findings are consonant with the idea that IgG 
antibody synthesis by hapten-primed B  cells may be elicited in an antigen- 
nonspecific fashion via the recognition of their Ia antigens by allogeneic T cells. 
By contrast, it appears that a syngeneic T cell-B cell interaction, which may also 
be mediated by the recognition of Ia antigens, is requisite to promote the switch 
in an antigen-specific response from IgM to IgG antibody production (25). 
The mechanism by which the recognition of allogeneic Ia antigens occurs in 
an IgG secondary response and its relationship to the process of normal B-cell 
activation is still not well defined. From the data presented here, it is apparent 
that AEF is an h-positive product of a  B  cell and/or macrophage which can 
activate B cells directly for IgG antibody synthesis in the absence of syngeneic 1030  AN  Ia-POSITIVE  ALLOGENEIC  EFFECT  FACTOR 
carrier-primed  T  cells.  This  type  of activation  may  occur  as  a  result  of a 
structural modification of Ia antigens in AEF afar their release from the surface 
ofa B cell or macrophage. One type of medification may occur via the association 
of a  T-cell-derived Ia-negative  component with  an  Ia molecule in AEF.  It is 
possible that the B cell possesses an acceptor molecule for this postulated T-cell 
product. Thus, a primed B cell may need to recognize both syngeneic Ia antigens 
and a T-cell Ia-negative signal to be suitably triggered in the presence of antigen 
to  IgG  antibody  synthesis.  If this  is  the  case,  it  is  possible  that  similarly 
modified antigen-specific Ia-positive B cell or macrophage-derived signals may 
mediate the process of hormal B-cell activation. A  further study of the mecha- 
nism and target of action of AEF, and its role in B-cell activation, is currently in 
progress. 
Summary 
A soluble allogeneic effect factor (AEF) was produced by using H-2 congenic 
mouse strains  and  a  serum.free  cell culture  medium.  An AEF derived from 
untreated  activated  responder  cells  and  irradiated  stimulator  cells  provided 
helper cell function in a  primary and secondary antibody response for both T- 
cell-depleted responder B cells and stimulator B cells. This interaction may be 
determined by genes situated in the I-A  and I-B  regions:  additional K-region 
control was not excluded. Ia antigens, but neither H-2 nor Ig determinants are 
molecular constituents of AEF.  The active components of this AEF consist, in 
part,  of Ia antigens  derived from both the activated responder cell population 
and irradiated  stimulator cell population. 
An  AEF  derived  from  Ia  negative  responder  cells  and  irradiated  T-cell- 
depleted stimulator cells helps a secondary antibody response of T-cell-depleted 
stimulator  B  cells but not responder  B  cells.  This genetically restricted AEF 
contains Ia  antigens  determined  by the  stimulator haplotype but not the re- 
sponder haplotype. The priming antigen,  DNP-keyhole limpet hemocyanin,  is 
not a component of restricted AEF. The data suggest that restricted AEF may be 
a product of a stimulator B cell and/or macrophage. They support the hypothesis 
that the recognition by allogeneic T cells of Ia antigens on B cells activates the B 
cell to IgG antibody production. 
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